Ethosuximide
Ethosuximide is a prescription medication used to treat absence seizures (petit mal epilepsy). This generic oral capsule, containing 250 mg of ethosuximide per dose, is manufactured by Strides Pharma Science Limited and approved under ANDA211928. It works by reducing abnormal electrical activity in the brain. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Ethosuximide is a prescription medication used to treat absence seizures (petit mal epilepsy). This generic oral capsule, containing 250 mg of ethosuximide per dose, is manufactured by Strides Pharma Science Limited and approved under ANDA211928. It works by reducing abnormal electrical activity in the brain. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Ethosuximide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Ethosuximide — ANDA 040253 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040253"
}
]
|
| identifier | ANDA040253 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Ethosuximide |
